Promegapoietin

N/A

Report date: 2022/01/25 15:56:40

NME

Base Information

Drug NamePromegapoietin

Drug Alias NamePMP

ClassificationSmall molecules > Synthetic peptide

Mechanisms of ActionThrombopoietin receptor agonists

TargetsThrombopoietin receptor

Therapy Area/IndicationsThrombocytopenia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsThrombocytopenia

ATC CodeN/A